OVOL1 Inhibits Breast Cancer Cell Invasion by Enhancing the Degradation of TGF-β Type I Receptor

Researchers showed that OVOL1 was inversely correlated with the epithelial–mesenchymal transition signature, and was an indicator of a favorable prognosis for breast cancer patients.